{
    "paper_id": "e418f3884e7e78ab596ff625fc4de9401b535b66",
    "metadata": {
        "title": "Distinct systems serology features in children, elderly and COVID patients 1 2",
        "authors": [
            {
                "first": "Kevin",
                "middle": [
                    "J"
                ],
                "last": "Selva",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Carolien",
                "middle": [
                    "E"
                ],
                "last": "Van De Sandt",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Melissa",
                "middle": [
                    "M"
                ],
                "last": "Lemke",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Michigan",
                    "location": {
                        "region": "Michigan",
                        "country": "USA 27"
                    }
                },
                "email": ""
            },
            {
                "first": "Christina",
                "middle": [
                    "Y"
                ],
                "last": "Lee",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Michigan",
                    "location": {
                        "region": "Michigan",
                        "country": "USA 27"
                    }
                },
                "email": ""
            },
            {
                "first": "Suzanne",
                "middle": [
                    "K"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Shoffner",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Michigan",
                    "location": {
                        "region": "Michigan",
                        "country": "USA 27"
                    }
                },
                "email": ""
            },
            {
                "first": "Brendon",
                "middle": [
                    "Y"
                ],
                "last": "Chua",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Thi",
                "middle": [
                    "H O"
                ],
                "last": "Nguyen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Louise",
                "middle": [
                    "C"
                ],
                "last": "Rowntree",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Luca",
                "middle": [],
                "last": "Hensen",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Marios",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Launceston General Hospital",
                    "location": {
                        "settlement": "Launceston",
                        "region": "Tasmania",
                        "country": "Australia; 28"
                    }
                },
                "email": ""
            },
            {
                "first": "Koutsakos",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Yi",
                "middle": [],
                "last": "Chinn",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Wong",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "David",
                "middle": [
                    "C"
                ],
                "last": "Jackson",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Katie",
                "middle": [
                    "L"
                ],
                "last": "Flanagan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Launceston General Hospital",
                    "location": {
                        "settlement": "Launceston",
                        "region": "Tasmania",
                        "country": "Australia; 28"
                    }
                },
                "email": ""
            },
            {
                "first": "Jane",
                "middle": [],
                "last": "Crowe",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Allen",
                "middle": [
                    "C"
                ],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "",
                "middle": [],
                "last": "Cheng",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Tasmania",
                    "location": {
                        "settlement": "Launceston",
                        "region": "Tasmania",
                        "country": "Australia; 29"
                    }
                },
                "email": ""
            },
            {
                "first": "Denise",
                "middle": [
                    "L"
                ],
                "last": "Doolan",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "James Cook 38 University",
                    "location": {
                        "settlement": "Cairns",
                        "region": "Queensland",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "Fatima",
                "middle": [],
                "last": "Amanat",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Florian",
                "middle": [],
                "last": "Krammer",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Keith",
                "middle": [],
                "last": "Chappell",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "The University of Melbourne",
                    "location": {
                        "addrLine": "19",
                        "postCode": "3000",
                        "settlement": "Victoria",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "Naphak",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Modhiran",
                "middle": [],
                "last": "14",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "The University of Melbourne",
                    "location": {
                        "addrLine": "19",
                        "postCode": "3000",
                        "settlement": "Victoria",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "Daniel",
                "middle": [],
                "last": "Watterson",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "The University of Melbourne",
                    "location": {
                        "addrLine": "19",
                        "postCode": "3000",
                        "settlement": "Victoria",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "Paul",
                "middle": [],
                "last": "Young",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "The University of Melbourne",
                    "location": {
                        "addrLine": "19",
                        "postCode": "3000",
                        "settlement": "Victoria",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "Bruce",
                "middle": [],
                "last": "Wines",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Melbourne",
                    "location": {
                        "settlement": "Pathology",
                        "region": "Vic",
                        "country": "Australia"
                    }
                },
                "email": ""
            },
            {
                "first": "P",
                "middle": [
                    "Mark"
                ],
                "last": "Hogarth",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "RMIT University",
                    "location": {
                        "settlement": "Melbourne",
                        "region": "Victoria, Australia. 32"
                    }
                },
                "email": ""
            },
            {
                "first": "Robyn",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Esterbauer",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hannah",
                "middle": [
                    "G"
                ],
                "last": "Kelly",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Hyon-Xhi",
                "middle": [],
                "last": "Tan",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Jennifer",
                "middle": [
                    "A"
                ],
                "last": "Juno",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Adam",
                "middle": [
                    "K"
                ],
                "last": "Wheatley",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Stephen",
                "middle": [
                    "J"
                ],
                "last": "Kent",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Kelly",
                "middle": [
                    "B"
                ],
                "last": "Arnold",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Katherine",
                "middle": [],
                "last": "Kedzierska",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, 25",
                    "institution": "University of Amsterdam",
                    "location": {
                        "postCode": "26",
                        "settlement": "Amsterdam",
                        "country": "Netherlands"
                    }
                },
                "email": ""
            },
            {
                "first": "Amy",
                "middle": [
                    "W"
                ],
                "last": "Chung",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "54 55 SARS-CoV-2, the pandemic coronavirus that causes COVID-19, has infected millions worldwide, 56 causing unparalleled social and economic disruptions. COVID-19 results in higher pathogenicity and 57 mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive 58 coronavirus immunological responses, induced by circulating human coronaviruses, is critical to 59 understand such divergent clinical outcomes. The cross-reactivity of coronavirus antibody responses 60 of healthy children (n=89), adults (n=98), elderly (n=57), and COVID-19 patients (n=19) were 61 analysed by systems serology. While moderate levels of cross-reactive SARS-CoV-2 IgG, IgM, and 62 IgA were detected in healthy individuals, we identified serological signatures associated with SARS-63 CoV-2 antigen-specific Fc\u03b3 receptor binding, which accurately distinguished COVID-19 patients 64 from healthy individuals and suggested that SARS-CoV-2 induces qualitative changes to antibody Fc 65 upon infection, enhancing Fc\u03b3 receptor engagement. Vastly different serological signatures were 66 observed between healthy children and elderly, with markedly higher cross-reactive SARS-CoV-2 67 IgA and IgG observed in elderly, whereas children displayed elevated SARS-CoV-2 IgM, including 68",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "receptor binding domain-specific IgM with higher avidity. These results suggest that less-experienced 69 humoral immunity associated with higher IgM, as observed in children, may have the potential to 70 induce more potent antibodies upon SARS-CoV-2 infection. These key insights will inform COVID-",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "In-depth characterization of cross-reactive SARS-CoV-2 Ab responses in healthy children compared 103 to healthy elderly is needed to understand whether pre-existing human coronavirus (hCoV)-mediated 104 Ab immunity potentially contributes to COVID-19 outcome. We designed a cross-reactive CoV 105 multiplex array, including SARS-CoV-2, SARS-CoV-1, MERS-CoV and hCoV (229E, HKU1, 106 NL63) spike (S) and nucleoprotein protein (NP) antigens (Extended Data Figure 1b) . CoV-antigen-107 specific levels of isotypes (IgG, IgA, IgM) and subclasses (IgG1, IgG2, IgG3, IgG4, IgA1, IgA2), 108 along with C1q binding (a predictor of ADCA via the classical pathway) and Fc\u03b3RIIa, Fc\u03b3RIIb and 109 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 454,
                    "end": 464,
                    "text": "Figure 1b)",
                    "ref_id": null
                }
            ],
            "section": ""
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 ",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "146"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 6 147 To interrogate Ab functionality and cross-reactivity between antigens of selected CoV signatures, we 148 conducted a correlation network analysis, focusing upon significant correlations of Ab features 149 selected by Elastic-Net. The children's network (Figure 1f ) demonstrates how SARS-CoV-2 Abs that 150 engaged Fc\u03b3RIIa-H131 are associated with SARS-CoV-2 IgG, specifically of IgG1 subclass. SARS-151 CoV-2 Fc\u03b3RIIa-H131 immune complex formation was also significantly correlated with multiple 152 other SARS-CoV-2 Fc responses, including Fc\u03b3RIIb, C1q, and Fc\u03b3RIIIa. Of interest, SARS-CoV-1 153 Abs that engaged FcgRIIIa-V158, were highly correlated with SARS-CoV-2 Ab responses, 154 potentially due to their high sequence similarity (77%) (Extended Data Figure 3) with Fc\u03b3R signatures to a range of CoV. Amino acid (aa) alignment analyses of NP and S1 proteins 162 showed that there is 91% (NP) and 77% (S1) aa similarity between SARS-CoV-2 and SARS-CoV-1 163 proteins, while SARS-COV-2 and MERS share 47% (NP) aa similarity, hCoVs NL63 and 229E share 164 29% and 26% aa similarity, respectively in NP, and hCoV HKU and 229E share 28% and 27% in S1, CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [
                {
                    "start": 365,
                    "end": 375,
                    "text": "(Figure 1f",
                    "ref_id": null
                },
                {
                    "start": 869,
                    "end": 878,
                    "text": "Figure 3)",
                    "ref_id": null
                }
            ],
            "section": "146"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. Table 3 ) were screened for SARS-CoV-2 antigen-specific serological profiles (Extended Data 186 Figure 4 ). An individual who was SARS-CoV-2-exposed but remained SARS-CoV-2 PCR-negative, 187 was also assessed (Donor DD1). Elevated SARS-CoV-2-specific Ab responses in COVID-19 patients 188 relative to healthy or the exposed but PCR-negative individual were observed across multiple 189 titrations (Extended Data Figure 4) . In particular, we found that in the majority of COVID-19 190 patients, the SARS-CoV-2 antigen-specific Abs bound to Fc\u03b3RIIIaV158 and Fc\u03b3RIIaH131 soluble 191 dimers at high levels, even at 1:800 plasma titrations, suggesting potent ADCC and ADCP CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 73,
                    "end": 80,
                    "text": "Table 3",
                    "ref_id": null
                },
                {
                    "start": 169,
                    "end": 177,
                    "text": "Figure 4",
                    "ref_id": null
                },
                {
                    "start": 485,
                    "end": 494,
                    "text": "Figure 4)",
                    "ref_id": null
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.11.20098459 doi: medRxiv preprint 8 notably being the healthy exposed SARS-CoV-2 PCR-negative individual (Figure 3d) The majority of COVID-19 moderate/severe samples were collected upon hospital presentation, 235 whereas mild samples were collected upon convalescence (Extended Data Table 3 ). Moreover, there 236 was no significant difference between these groups after adjusting for multiple comparisons, which is 237 not surprising given the small sample size (Extended Data Table 4 with Ab avidity, we therefore conducted urea disassociation assays on a subset of children, elderly 257 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 212,
                    "end": 223,
                    "text": "(Figure 3d)",
                    "ref_id": null
                },
                {
                    "start": 385,
                    "end": 397,
                    "text": "Data Table 3",
                    "ref_id": null
                },
                {
                    "start": 580,
                    "end": 592,
                    "text": "Data Table 4",
                    "ref_id": "TABREF8"
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10.1101/2020.05.11.20098459 doi: medRxiv preprint 9 and COVID-19 plasma samples (Figure 4c -iv, 4d-iv). No differences in IgA avidity were found 258 between children, elderly and COVID-19 patients. Avidity of RBD-specific IgM from elderly was 259 significantly weaker than COVID-19 patients (p=0.0177), while children's responses, spanning a 260 large range of avidities, were not significantly different (p=0.0696). These data, in combination with 261 the overall higher IgM frequency in children, suggest that children may trend to have more potent 262 RBD-specific IgM which may mature more rapidly upon SARS-CoV-2 exposure, as compared to the 263 elderly. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 171,
                    "end": 181,
                    "text": "(Figure 4c",
                    "ref_id": null
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "335"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "390"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "439"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 13 HLA-DQB1, -DRB1 and -DPB1 alleles in our healthy donor cohort (a,d,g) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 171,
                    "end": 178,
                    "text": "(a,d,g)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 14 Melbourne. Healthy elderly donors (age 65-92) were recruited at the Deepdene Medical Clinic 477 (Victoria). All healthy donors were recruited prior to SARS-CoV-2 pandemic. SARS-CoV-2-infected 478 patients (age 21-75) were recruited at the Alfred Hospital (AH). Convalescent individuals who 479 recovered from COVID-19 were recruited by James Cook University (DD) or University of 480 Melbourne (CP). Eligibility criteria for COVID-19-acute and convalescent recruitment were age \u226518 481 years old and having at least one swab PCR-positive for SARS-CoV-2. Each patient was categorized 482 into one of the following 6 severity categories: very mild (stay at home minimal symptoms), mild 483 (stay at home with symptoms), moderate (hospitalized, not requiring oxygen), severe/moderate 484 (hospitalized with low flow oxygen), severe (hospitalized with high flow oxygen) or critical (intensive 485 care unit (ICU)). Heparinised blood was centrifuged for 10 min at 300 g to collect plasma, which was CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 15 Krammer) 24 , SARS-CoV-2 Trimeric S (gift from Adam Wheatley) and SClamps of both SARS-CoV-514 2 and MERS-CoV (gift from University of Queensland) (Extended Data Figure 1b) . Tetanus toxoid 515 (Sigma) and influenza hemagglutinin (H1Cal2009; Sino Biological), were also added to the assay as 516 positive controls, while BSA blocked beads were included as negative controls. Magnetic 517 carboxylated beads (Bio Rad) were covalently coupled to the antigens using a two-step carbodiimide 518 reaction, in a ratio of 10 million beads to 100\u00b5g of antigen, with the exception of the deglycosylated 519 NPs mentioned above in which 40\u00b5g were used instead. Briefly, beads were washed and activated in 520 100 mM monobasic sodium phosphate, pH 6.2, followed by the addition of Sulfo-N- For the detection of IgM, biotinylated mouse anti-human IgM (mAb MT22; MabTech) was added at 547 1.3\u00b5g/ml, 25\u00b5l per well. After incubation at RT for two hours on a shaker, the plate was washed, and 548 streptavidin, R-Phycoerythrin conjugate (SAPE; Invitrogen) was added at 1\u00b5g/ml, 25\u00b5l per well. The 549 plate was then incubated at RT for two hours on a shaker before being washed and read as mentioned 550 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [
                {
                    "start": 271,
                    "end": 281,
                    "text": "Figure 1b)",
                    "ref_id": null
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "587"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 17 588 Statistical Analysis 589 Children versus the elderly Volcano plot was conducted using Prism 8. Statistical significance 590 determined using the Holm-Sidak method, with alpha = 0.05 adjusted for 196 tests (Ab features). Each 591 feature was analyzed individually, without assuming a consistent SD. The overall multiplex dataset was 592 analysed for normal distribution using the Shapiro-Wilk test by Prism 8 The data were further 593 analysed by SPSS statistics 26 (IBM Corp.) using the Kruskal-Wallis one-way analysis with a 594 Bonferroni correction to determine the p-values, differences between groups were considered 595 significant at an adjusted p-value of 0.000035 (Extended data Table 2 ). ELISA data was analyzed 596 using Kruskal-Wallis one-way analysis with Dunn's multiple comparison using Prism 8. Differences 597 between very mild/mild and moderate/severe/critical patients were analysed using the Mann-Whitney 598 test and differences were considered significant at a p-value of 0.05 (Extended data individually if it contained any negative values, by adding the minimum value for that feature back to 610 all samples within that feature. Following this all data was log transformed using the following 611 equation, where x is the right shifted data and y is the right shifted log transformed data: y = 612 log10(x+1). This process transformed the majority of the features to having a normal distribution. In 613 all subsequent multivariate analysis, the data were furthered normalized by mean centring and 614 variance scaling each feature using the zscore function in Matlab. For the HLA analysis, the same 615 data normalization methods were used, except that positive controls were included and all samples 616 with any HLA typing were included. Samples with one copy of each most frequent allele were 617 removed to avoid double classification.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [
                {
                    "start": 801,
                    "end": 808,
                    "text": "Table 2",
                    "ref_id": null
                }
            ],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "Feature Selection Using Elastic Net/PLSR and Elastic Net/PLSDA 620 To determine the minimal set of features (signatures) needed to predict numerical outcomes (age, days 621 from symptom onset) and categorical outcomes (age cohort, COVID-19 infection status, HLA Allele) 622 a three-step process was developed based on 41 . First, the data were randomly sampled without 623 replacement to generate 2000 subsets. The resampled subsets spanned 80% of the original sample 624 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "619"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 ",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "619"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "776"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 ",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "776"
        }
    ],
    "bib_entries": {
        "BIBREF1": {
            "ref_id": "b1",
            "title": "PCA, PLSDA, and PLSR scores and loadings plots were plotted in Prism 702 version. Statistical analysis were performed in SPSS. Multiple sequence alignment was",
            "authors": [],
            "year": 2017,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Jalview 2.10.5 and distance matrix for multiple alignments was done in Ugene 1",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "16",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "The source data underlying Figs 1-4, Extended data Figs 1, 2, 4, 5, 6, Extended Data table 2 and 4 are 708 provided as a Source Data file. The coding used for analysis can be found in the Source Coding file",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "All other data are available from the authors upon request",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "High-throughput, multiplexed IgG subclassing of antigen-specific 714 antibodies from clinical samples",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "P"
                    ],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Journal of immunological methods",
            "volume": "386",
            "issn": "",
            "pages": "117--123",
            "other_ids": {
                "DOI": [
                    "10.1016/j.jim.2012.09.007"
                ]
            }
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a 717",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Stadlbauer",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Serological Assay, Antigen Production, and Test Setup",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "57",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1002/cpmc.100"
                ]
            }
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Enhanced binding of antibodies generated during chronic HIV infection to 720 mucus component MUC16",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Gunn",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mucosal Immunol",
            "volume": "9",
            "issn": "",
            "pages": "1549--1558",
            "other_ids": {
                "DOI": [
                    "10.1038/mi.2016.8"
                ]
            }
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Regularization and variable selection via the elastic net",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Hastie",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Journal",
            "volume": "722",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "We thank all the participants involved in the study, Ebene Haycroft and Brendan Watts for 728",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "This work was supported by Jack Ma Foundation to KK",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Craig Foundation to KLF and KK, NHMRC Leadership Investigator Grant to KK 730 (1173871), NHMRC Program Grant to KK (1071916)",
            "authors": [
                {
                    "first": "The",
                    "middle": [],
                    "last": "Aw",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Clifford",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Research Grants Council of the Hong Kong Special 732",
            "authors": [],
            "year": null,
            "venue": "NHMRC program grant to SJK (#1149990)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Administrative Region, China (#T11-712/19-N) to KK. AWC is supported by a NHMRC Career 733",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "DLD 734 by a NHMRC Principal Research Fellowship (#1137285). SJK by NHMRC Senior Principal Research 735",
            "authors": [],
            "year": null,
            "venue": "Development Fellowship (#1140509), KK by NHMRC Senior Research Fellowship (1102792)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "CES has received funding from the European Union's Horizon 2020 research 736 and innovation program under the Marie Sk\u0142odowska-Curie grant agreement No 792532. LH is 737 supported by the Melbourne International Research Scholarship (MIRS) and the Melbourne 738 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "International Fee Remission Scholarship (MIFRS) from The University of Melbourne",
            "authors": [],
            "year": null,
            "venue": "NHMRC Early Career Fellowship (ECF) (APP1123673)",
            "volume": "739",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Correspondence and requests for materials should be addressed to Katherine Kedzierska and Amy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Figure 1. Vastly different serological signatures between children and elderly 759 (a) Volcano plot of children (orange) versus elderly (dark blue), open circles are not significantly 760 different between two groups. Data was zscored prior to analysis. (b) PCA of all 196 Ab features for 761 healthy children, adults (light blue square), and elderly. PLSDA scores (c) and loadings plots (d) 762 using the 15-feature Elastic-Net selected signature for children versus elderly (0.88% calibration 763 error, 1.44% cross-validation error). Variance explained on each LV is in parentheses. Statistically 764 significant separation of groups was determined using a two-tailed t-test on LV1 scores p<0.0001, t = 765 21.60 (e) Hierarchical clustering of Elastic-Net selected features for children and elderly. Levels are 766 coloured from low (dark blue) to high (dark red). Correlation network analyses for children (f) and 767 elderly (g)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Ab feature type (colour), antigen (shape), correlation strength (line thickness, alpha <0.05), and 769 correlation coefficient",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Analysis was performed on a subset of the healthy individuals (n=111) for whom HLA 778 class II type was available. Donors heterozygotes for the two most frequent HLA alleles were 779 excluded from PLSDA and loading analysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Figure 3. Healthy versus COVID-19 serological signatures",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Hierarchical clustering (d) and PLSDA model 784 scores (e) and loadings (f) were performed using the four-feature Elastic-Net selected SARS-CoV-2 785 antigen signature (1.49% calibration error, 1.49% cross-validation error). Variance explained by each 786 LV is in parentheses. (g) Correlation network analysis for COVID-19 patients was performed to 787 identify features significantly associated with the Elastic-Net selected features",
            "authors": [],
            "year": null,
            "venue": "Hierarchical clustering of all SARS-CoV-2 antigens for IgM",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Ab feature type (colour), antigen (shape), correlation strength (line thickness, alpha <0.05) and 789 correlation coefficient (line colour). Data was zscored prior to analysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "COVID-19 Ab responses over time and RBD Abs in healthy versus COVID-19",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "PLSR model scores plot (a) loadings plot (b) for all COVID-19 patient data on Elastic-Net 15-feature 793 signature. The model goodness of fit (R 2 ) was 0.8361 and goodness of predication",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Percent variance explained by each latent variable in parenthesis. Multiplex MFI data for IgM (c-i)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Children (orange), adults (light blue), elderly (dark blue) and COVID-19 patients (red)",
            "authors": [],
            "year": null,
            "venue": "ELISA endpoint titers for IgM (c-ii)",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Wallis with Dunn's multiple comparisons, exact p-values are provided",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Extended Data Figure 1. Multiplex Assay setup and optimization 802 (a-i-iii) Schematic of bead-based multiplex assay. (b) Overview of antigens included in the assay",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Multiplex was validated by measuring a subset of healthy samples both in singleplex and multiplex",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Strong correlations suggest that multiplexing did not affect measurement of Ab responses",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "approximately 20% of cases have more severe disease outcomes involving hospitalization 77 or intensive care treatment, especially in those with underlying co-morbidities such as diabetics and 78 cardiovascular disease 3 . Furthermore, COVID-19 related morbidity and mortality is significantly 79 higher in the elderly population and almost absent in school-aged children 4 . A disproportional 80 outcome in disease severity with increasing age is not unique to the SARS-CoV-2 pandemic, and is 81 observed during previous influenza pandemics 5 . Understanding whether baseline pre-existing 82 immunological responses, induced by previous exposure to seasonal coronaviruses, contributes to 83 such differences may provide important insights to such divergent clinical outcomes between Abs) are a vital component of the immune response with demonstrated importance in the 87 control of most viral pathogens. Apart from virus neutralization, Abs have the capacity to engage Fc 88 Receptors (FcRs) or complement to induce Fc effector functions, including Ab-dependent cellular 89 cytotoxicity (ADCC), Ab-dependent cellular phagocytosis (ADCP), or Ab-dependent complement 90 activation (ADCA) 6 . Fc functions are not limited to neutralizing viral epitopes but utilize any 91 available epitope 6 . A previous SARS-CoV (also called SARS-CoV-1) study associated ADCP with 92 viral clearance 7 , where individuals expressing a higher affinity Fc\u03b3RIIa-H131 polymorphism, 93 associated with enhanced Fc functions, had better disease outcomes 8 . However Fc functional Abs may 94 also enhance infection or pathology through Ab-dependent enhancement (ADE), previously observed 95 in some SARS-CoV-1 animal vaccine and in vitro studies 9,10 . Hence, there is an urgent need to 96 understand the Ab responses elicited against SARS-CoV-2, especially given that current COVID-19 97 vaccine strategies are focused upon inducing effective neutralizing Ab responses 11 ,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "CoV Ab responses between children and elderly, identifying 58 of 196 (29.6%) Ab 115 features as significantly different, taking into account multiple comparisons (all p<0.00037; Figure 116 1a; Extended Data Table 2). The volcano plot illustrates the eight Ab features (left) elevated in 117 children, consisting of IgM targeting a range of CoV antigens, including several SARS-CoV-2 118 antigens (S, NP, and the receptor binding domain (RBD), which is involved in binding to host cells 119 and is a key target of neutralizing Abs). Additionally, we observed elevated SARS-CoV-2 Abs that 120 engaged Fc\u03b3RIIa-H131 soluble dimers, associated with increased ADCP responses 13 . Conversely, 50 121 significantly elevated features were observed in the elderly, primarily consisting of IgA and IgG 122 against a range of CoV antigens, along with hCoV-specific Abs that can bind soluble serology 15 , we observed vastly different CoV serological signatures between children 126 and elderly (Figure 1). Unsupervised multidimensional visualization (Principal Component Analysis; 127 PCA) of all 196 CoV Ab features clearly distinguished children from elderly, with adults spanning 128 these two cohorts although clustering more closely to the elderly (Figure 1b). To identify the minimal 129 signatures of Ab features that best distinguished children from elderly, we performed feature selection 130 (Elastic-Net) followed by a supervised multidimensional clustering analysis (Partial Least Squares 131 Discriminant Analysis; PLSDA). Fifteen Ab features selected by Elastic-Net could accurately 132 discriminate between children and elderly (99.1% calibration, 98.6% cross-validation accuracy). 133 Significant separation of PLSDA scores occurred across the first Latent Variable (LV1) (p<0.0001, t 134 = 21.60, LV1-X axis, which accounted for 29.87% of the signature's total variance; Figure 1c). The 135 loadings plot of LV1 (Figure 1d) confirmed that children have elevated IgM to a range of CoV 136 antigens, and elevated SARS-CoV-2 Abs that engaged FcgRIIa-H131 soluble dimers, but also SARS-137 CoV-1 Abs that engaged Fc\u03b3RIIIa. In comparison, the elderly had elevated IgA, IgG, and Fc\u03b3RIIIa 138 binding Abs to CoV antigens. To better visualize how these Ab features could distinguish children 139 from elderly, we performed unsupervised hierarchical clustering and illustrate that the same 140 serological signatures naturally cluster the majority of children from the elderly (Figure 1e). Notably, 141 there were no differences in baseline CoV serological profiles between the sexes (Figure 1e), despite 142 males being clinically associated with higher mortality and more severe COVID-19 4 . Correlates of Ab 143 signatures were further confirmed by feature selection followed by multivariate regression analysis 144 (Partial Least Squared Regression; PLSR), including all healthy individuals to analyse correlates 145 across age (Extended Data Figure 2).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "RBD responses (Figure 1g). Additionally, they had elevated SARS-CoV-2 NP Abs correlating 161",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "165 respectively (Extended Data Figure 3c), supporting the network analyses. Collectively, these data 166 suggest that children have less exposure to CoV antigens but may have enhanced primary humoral 167 immune responses targeted to SARS-CoV-2 compared to elderly. 168 169 HLA-II alleles influence Ab signatures 170 HLA class II allele information was available for a subset of the healthy individuals (children n=84, 171 adults n=17, elderly n=10, Figure 2; Extended Data Table 1). To determine whether HLA-II alleles 172 contributed to differences in Ab predisposition, we conducted Elastic-Net and PLSDA to distinguish 173 Ab responses between the two most frequently observed HLA-DQB1, -DRB1 or -DPB1alleles in our 174 cohort (Figure 2a, d and g). Intriguingly, HLA-DQB1*03:01 and HLA-DQB1*06:02 were 175 associated with distinct Ab features (Figure 2b-c; calibration 86.4%, and 82.6% cross-validation 176 accuracy), as were HLA-DRB1*07:01 and HLA-DRB1*15:01 (Figure 2e-f; calibration 79.1%, and 177 76.3% cross-validation accuracy), along with HLA-DPB1*04:01 and HLA-DPB1*02:01 (82.3% 178 calibration and 72.2% cross-validation accuracy; Figure 2h-i). These results suggest that HLA-II 179 allelic repertoires of individuals may affect the development of Ab responses after infection or 180 vaccination, possibly contributing to the variable antigen-specific Ab titers and/or signatures",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "we analysed whether COVID-19 patients had distinct serological patterns of SARS-CoV-2 195 antigen-specific Abs of a single isotype (IgG, IgA, or IgM) compared to healthy individuals 196 (including DD1) using hierarchical clustering. While majority of COVID-19-positive individuals 197 induced high SARS-CoV-2-specific IgM responses, especially to spike antigens, moderate levels of 198 cross-reactive SARS-CoV-2-specific IgM were also detected at high frequencies within the healthy 199 individuals (Figure 3a). Similarly, moderate SARS-CoV-2-specific IgA (Figure 3b) and IgG (Figure 200 3c) were observed in healthy individuals, though less frequently than IgM, with cross-reactive IgG 201 responses observed at the lowest frequencies of all isotypes (Figure 3c). Overall, moderate levels of 202 SARS-CoV-2 cross-reactive Abs in healthy donors resulted in poor clustering of COVID-19 patients 203 from healthy individuals when a single isotype were assessed, even though multiple SARS-CoV-2 204 antigens were included. This suggests that reported low levels of false positives in current serological 205 diagnostics tests could be due to pre-existing levels of cross-reactive Abs that lead to similar 206 serological signatures as observed in SARS-CoV-2-infected individuals when only quantity the minimum Ab signature that best distinguish the COVID-19 patients from healthy 210 individuals, feature selection was used and identified four SARS-CoV-2 Ab variables that 211 differentiated the two groups (Figure 3d-f), targeting three different SARS-CoV-2 antigens, S trimer, 212 (fold on stabilized spike ectodomain, 2P mutation 17 ), NP, and Sclamp (molecular clamp stabilized 213 spike ectodomain 18 ). Intriguingly, antigen-specific engagement of Fc\u03b3RIIIaV158 and C1q, but not 214 IgG, were selected. This suggests that SARS-CoV-2 infection likely induces antigen-specific Ab with 215 distinct Fc qualities, e.g. Fc glycosylation changes, enhancing binding of Fc\u03b3RIIIaV158 and C1q 19,20 , 216 unlike pre-existing cross-reactive SARS-CoV-2 Abs observed in our healthy donor cohort. In contrast 217 to previous unsupervised hierarchical clustering for IgA, IgM, and IgG (Figure 3a-c) to multiple 218 SARS-CoV-2 antigens, these four SARS-CoV-2 Ab features had distinct patterns in COVID-19 219 patients, which lead to the clustering of COVID-19 patients together with a single exception, this 220 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "223and f, p<0.0001, t=34.80; 98.51% calibration accuracy, 98.51% cross-validation accuracy). To 224 specifically define these four SARS-CoV-2 Ab features, we conducted a correlation network of Ab 225 responses in the COVID-19-positive individuals(Figure 3g). High levels of correlation were 226 observed between all SARS-CoV-2 spike antigens: S1, S2, RBD, S Trimer, and Sclamp; while NP 227 antigen-specific Ab features created a separate network. Antigen-specific IgG1 and IgG3, which are 228 the most highly functional IgG subclasses 21,22 , were the key mediators of Fc\u03b3R and C1q antigen-229 specific Ab engagement. Collectively, these results suggest that future COVID-19 serological 230 diagnostic tests could be improved by assessing the Fc quality of antigen-specific Abs in",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "). To explore CoV Ab responses 238 over time, we performed feature selection followed by multivariate regression analysis (PLSR) 239 according to days from first reported disease symptom onset. Not surprisingly, we observed similar 240 Ab signatures to those differentiating healthy from COVID-19 positive individuals, including SARS-241 CoV-2 antigen-specific Ab engagement with Fc\u03b3R, C1q, and IgG3 being the most predominant 242 variables associated with convalescence (Figure 4a-b, R 2 =0.84, Q 2 =0.72), with several of these Ab 243 features individually associated with days from symptom onset (Extended Data Figure 5). These 244 data are the first indication that SARS-CoV-2 antigen-specific Ab Fc effector functions may development of neutralizing Ab responses targeting the RBD are associated with control of 249 SARS-CoV-2, occurs in the majority of convalescent COVID-19 serum samples 23 . Therefore, 250 baseline RBD isotype-specific levels between healthy children, adults, elderly and COVID-19 patient 251 plasma samples were assessed via multiplex-assay and validated with published ELISA methods 24 252 (Figure 4c-i-ii, d-i-ii, e-i-ii). Ab detection in both assays was highly correlated (Figure 4c-iii, d-iii, e-253 iii), confirming earlier observations that children induced elevated IgM, while elderly had higher 254 RBD-specific IgA1 responses as measured by multiplex and trended with ELISA IgA results, while 255 no differences in IgG were observed. Since Ab neutralization quality and potency is often correlated 256",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "distinct cross-reactive coronavirus serological signatures in healthy children compared 267 to elderly. Children had elevated CoV-specific IgM signatures, whereas elderly had more mature, 268 class-switched CoV-specific IgA and IgG, despite previous epidemiological studies observing higher 269 levels of hCoV infection amongst children compared to the elderly 25 , indicating that multiple rounds 270 of infections over decades might be needed to develop fully experienced CoV humoral immune 271 responses. Intriguingly, school-aged children often have better clinical outcomes during pandemic 272 influenza outbreaks 5 and can induce more potent broadly-neutralising Ab upon HIV infection 26,27 . It is 273 plausible that upon infection with SARS-CoV-2, the elderly may preferentially induce skewed Ab 274 responses targeting prior cross-reactive hCoV antigens, unlike children who have less experienced 275 immunity and are therefore more likely to mount a more targeted immune response to novel antigens 276 from SARS-COV-2. This immunological phenomenon, known as the Hoskins effect (original antigen 277 sin), observed for several other viral pathogens including influenza and dengue 28,29 and hypothesized 278 to contribute to enhanced cytokine storm upon dengue reinfection 30 . These hypotheses will need to be 279 confirmed by future studies examining cross-reactive CoV serological signatures from longitudinal 280 sampling of acute SARS-CoV-2-infected children and elderly. 281 282 Our results indicate HLA-II alleles contribute to differences in Ab signatures prior to antigen 283 exposure, which could potentially impact antigen-specific Ab profiles upon infection, this field has 284 thus far not been studied and could be associated with antigenic sin. Establishment of an effective 285 humoral immune response after infection and vaccination depends on generation of affinity-matured 286 long-lived plasma cells and memory B cells and is correlated with effective activation of T follicular 287 helper (T FH ) cells 31 , which depend on the effective presentation of viral epitopes via HLA-II alleles. 288 Several studies demonstrate that variations in HLA-II alleles are associated with susceptibility or 289 resistance to several infectious diseases including MERS-CoV 32,33 and with vaccine-induced Ab 290 responses 34 . Due to the low frequency of shared HLA-II alleles, this analysis could not be further 291 explored to determine the contribution of age or sex. However, the clear distinction in Ab signatures 292 emphasizes the need to better understand the contributions of HLA-II alleles to the maturation of 293 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF9": {
            "text": "our in-depth serological profiling of healthy children, elderly, and COVID-19 patients brings 313 us closer to understanding why the elderly are more susceptible to COVID-19 and provides insights 314 into Ab Fc signatures associated with convalescence of mild/moderate symptomatic individuals. This 315 knowledge is important for the development of improved serological diagnostics, evaluation of 316 convalescent plasma therapeutic trials and will inform immunogenicity assessment of Ab-based 317 SARS-CoV-2 vaccine strategies which could potentially extend beyond neutralizing Abs.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF10": {
            "text": "F. S., D.; Strohmeier, S,; Nguyen, T.H.O.; Chromikova, V.; McMahon, M.; Jiang, 380 K.; Arunkumar, G.A.; Jurczyszak, D.; Polanco, J.; Bermudez-Gonzalez, M.;, Kleiner, G.; 381 Aydillo, T.; Miorin, L.; Fierer, D.; Lugo, L.A.; Kojic, E.M.; Stoever, J.; Liu, S.T.H.; 382 Cunningham-Rundles, C.; Felgner, P.L.; Moran, T.;1, Garc\u00eda-Sastre, A.; Caplivski, D.; 383 Cheng, A.C.; Kedzierska, K.; Vapalahti, O.; Hepojoki, J.M.; Simon, V.; Krammer, F. A 384 serological assay to detect SARS-CoV-2 seroconversion in humans. Nature Medicine In 385 Press (2020). 386 25 Gaunt, E. R., Hardie, A., Claas, E. C., Simmonds, P. & Templeton, K. E. Epidemiology and 387 clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 388 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol 48, 389 2940-2947, doi:10.1128/JCM.00636-10 (2010).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF11": {
            "text": "M. R., Lu, L. L., Kent, S. J. & Chung, A. W. An Inflammatory Story: Antibodies in 421 Tuberculosis Comorbidities. Front Immunol 10, 2846, doi:10.3389/fimmu.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF12": {
            "text": "Vastly different serological signatures between children and elderly 426 (a) Volcano plot of children (orange) versus elderly (dark blue), open circles are not significantly 427 different between two groups. Data was zscored prior to analysis. (b) PCA of all 196 Ab features for 428 healthy children, adults (light blue square), and elderly. PLSDA scores (c) and loadings plots (d) 429 using the 15-feature Elastic-Net selected signature for children versus elderly (0.88% calibration 430 error, 1.44% cross-validation error). Variance explained on each LV is in parentheses. Statistically 431 significant separation of groups was determined using a two-tailed t-test on LV1 scores p<0.0001, t = 432 21.60 (e) Hierarchical clustering of Elastic-Net selected features for children and elderly. Levels are 433 coloured from low (dark blue) to high (dark red). Correlation network analyses for children (f) and 434 elderly (g) identify features associated with the Elastic-Net selected features (red outline). Coded by 435 Ab feature type (colour), antigen (shape), correlation strength (line thickness, alpha <0.05), and 436 correlation coefficient (line colour).437 HLA-II alleles influence Ab signatures",
            "latex": null,
            "type": "figure"
        },
        "FIGREF13": {
            "text": "Healthy versus COVID-19 serological signatures 449 Hierarchical clustering of all SARS-CoV-2 antigens for IgM (a), IgA1 (b) and IgG (c). Levels are 450 coloured from low (dark blue) to high (dark red). Hierarchical clustering (d) and PLSDA model 451 scores (e) and loadings (f) were performed using the four-feature Elastic-Net selected SARS-CoV-2 452 antigen signature (1.49% calibration error, 1.49% cross-validation error). Variance explained by each 453 LV is in parentheses. (g) Correlation network analysis for COVID-19 patients was performed to 454 identify features significantly associated with the Elastic-Net selected features (red outline). Coded by 455 Ab feature type (colour), antigen (shape), correlation strength (line thickness, alpha <0.05) and 456 correlation coefficient (line colour). Data was zscored prior to analysis. 457 COVID-19 Ab responses over time and RBD Abs in healthy versus COVID-19 459 PLSR model scores plot (a) loadings plot (b) for all COVID-19 patient data on Elastic-Net 15-feature 460 signature. The model goodness of fit (R 2 ) was 0.8361 and goodness of predication (Q 2 ) was 0.7194.461 Percent variance explained by each latent variable in parenthesis. Multiplex MFI data for IgM (c-i), 462 IgA (d-i) and IgG (e-i), ELISA endpoint titers for IgM (c-ii), IgA (d-ii) and IgG (e-ii), and their 463 respective correlations (c-e iii). Avidity index following urea dissociation for IgM (c-iv) and, IgA (d-464 iv). Children (orange), adults (light blue), elderly (dark blue) and COVID-19 patients (red). Bar 465 indicates the median response of each group. Statistical significance was determined using-Kruskal 466 Wallis with Dunn's multiple comparisons, exact p-values are providedpatients (Extended Data Figure 2a, Table 1 and 3). Children undergoing elective 473 tonsillectomy (age 1.5-19) were recruited at the Launceston General Hospital (Tasmania) and, apart 474 from fulfilling the criteria for tonsillectomy, they were considered otherwise healthy, showing no 475 signs of immune compromise. Healthy adult donors (age 22-63) were recruited via the University of 476 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF14": {
            "text": "work was conducted according to the Declaration of Helsinki principles and 490 according to the Australian National Health and Medical Research Council Code of Practice. All 491 donors or their legal guardians provided written informed consent. The study was approved by the 492 Human Research Ethics Committee (HREC) of the University of Melbourne (Ethics ID #1443389.4, 493 #2056761, #1647326, #2056689, #1955465) for healthy adult and elderly donors, Tasmanian Health 494 and Medical HREC (H0017479) for healthy child donors, Alfred Hospital (#280/14) for AH donors, 495 James Cook University (#H7886) for DD donors and University of Melbourne (#2056689) of E. coli-expressed NP 499 To minimise background from the E. coli expression system, recombinant hCoV 229E and NL63 NP 500 (Prospec-Tany) were first treated with O-glycosidase and PNGase F. Briefly, 40\u00b5g of NP were treated 501 with a cocktail of 8\u00b5l 10X GlycoBuffer 2, 8\u00b5l 10% NP40, 12\u00b5l O-Glycosidase, 12\u00b5l of Remove-iT 502 PNGase F (New England BioLabs) and water for a final volume of 80\u00b5l and incubated at 37\u00b0C for 503 two hours on a shaker. The respective mixtures were added to Eppendorf tubes containing 100\u00b5l of 504 PSB-washed Chitin magnetic beads (New England BioLabs) to allow the binding and removal of 505 Remove-iT PNGase F. Tubes were agitated for 10 minutes then placed onto a magnetic separation 506 rack for 5 minutes. The supernatant was retrieved and passed through a 100kDa Amicon Ultra 507 centrifugal filter (Merck) to remove remaining O-glycosidase. Finally, NPs were washed with PBS 508 using a 3kDa Amicon Ultra centrifugal filter (Merck) to prepare them for coupling. 509 510 Coupling of carboxylated beads 511 A custom CoV multiplex assay was designed with SARS-CoV-2, SARS-CoV-1, MERS-CoV and 512 hCoV (229E, HKU1, NL63) S and NP antigens, as well as SARS-CoV-2 RBD (gift from Florian 513 .",
            "latex": null,
            "type": "figure"
        },
        "FIGREF15": {
            "text": ". After incubation at room temperature (RT) for 30 minutes, the activated microspheres 523 were washed three times and resuspended in 50mM MES pH 5.0 (Thermo Fisher Scientific). The 524 respective antigens were added to the activated beads and the mixture was incubated at RT for three 525 hours on a rotator in the dark. Subsequently, the beads were washed with PBS and blocked with 526 blocking buffer (PBS, 0.1% BSA, 0.02% TWEEN-20, 0.05% Azide, pH 7) for 30 minutes. Finally, 527 beads were washed in PBS 0.05% Sodium Azide and resuspended to one million beads per 100\u00b5l.528 529Luminex bead-based multiplex assay530The isotypes and subclasses of pathogen-specific antibodies present in the collected plasma were 531 assessed using a multiplex assay as described 39 . Using a black, clear bottom 384-well plate (Greiner 532 Bio-One), 20\u00b5l of working bead mixture containing 1000 beads per bead region and 20\u00b5l of diluted 533 plasma were added per well. From validation experiments in which cross-reactive Abs present in 534 healthy individuals were titrated, an optimal concentration of 1:100 working dilution of plasma was 535 selected for downstream assays (Extended dataFigure 1c and d). The plate was covered and 536 incubated overnight at 4\u00b0C on a shaker and was then washed with PBS containing 0.05% Tween20 537 (PBST). Pathogen-specific antibodies were detected using phycoerythrin (PE)-conjugated mouse anti-538 human pan-IgG, IgG1-4, IgA1-2 (Southern Biotech), at 1.3\u00b5g/ml, 25\u00b5l per well. After incubation at 539 RT for two hours on a shaker, the plate was washed, before the beads were resuspended in 50 \u00b5l of 540 sheath fluid. The plate was then incubated at RT for 10 minutes on a shaker before being read by the 541 FlexMap 3D. The binding of the PE-detectors was measured to calculate the median fluorescence 542 intensity (MFI). Double background subtraction was conducted, removing first background of blank 543 (buffer only) wells followed by removal of BSA-blocked control bead background signal for",
            "latex": null,
            "type": "figure"
        },
        "FIGREF16": {
            "text": "558titration of AH0073 was included in the layout of all multiplex array plates as this patient was known 559 to have IgG, IgM and IgA responses (Extended DataFigure 6). These titrations were RBD-specific antibodies was performed as described inStadlbauer et al 24,40  with the 565 following modifications; Nunc MaxiSorp flat bottom 96-well plates (Thermo Fisher Scientific) were 566 used for antigen coating, blocking performed with PBS containing 10% BSA and serial dilutions 567 performed with PBST containing 5% BSA. For detection of IgG and IgA, peroxidase-conjugated goat 568 anti-human IgG (Fc\u03b3 fragment specific; Jackson ImmunoResearch) or alkaline phosphate-conjugated 569 rat anti-human IgA (mAb MT20; MabTech), was used and developed with TMB (Sigma) substrate for 570 IgG or pNPP (Sigma) for IgA. For IgM, biotinylated mAb MT22 and peroxidase-conjugated 571 streptavidin (Pierce; Thermo Fisher Scientific) was used. Peroxidase reactions were stopped using 1M 572 H3PO4 and plates read at 450nm or 405nm on a Multiskan plate reader (Labsystems). All 573 measurements were normalised using a positive control plasma from a COVID-19 patient (AH0073) 574 run on each plate (Extended data Figure 6). Endpoint titres were determined by interpolation from a 575 sigmodial curve fit (all R-squared values >0.95; GraphPad Prism 8) as the reciprocal dilution of 576plasma that produced \u226515% absorbance of the positive control. A total of 28 donors from each cohort 577 was randomly selected for IgA analysis, 14 for IgG and 10-14 for IgM. All assays also antibodies in plasma samples was measured using urea as the chaotropic agent and only 582 performed on samples with detectable RBD-specific antibodies (IgA and IgM). Following incubation 583 of plasma at a 1:10 dilution (IgA) or 1:100 dilution (IgM) on RBD-coated plates, 6M of urea was 584 added and incubated for 15 minutes. Bound antibodies were then detected using respective secondary 585 detection reagents described above. The avidity index is expressed as the percentage of remaining 586 antibody bound to antigen following urea treatment compared to the absence of urea.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF17": {
            "text": "multivariate analysis Tetanus, H1Cal2009 antigens (positive controls) were removed, with the 602 exception of HLA analysis. Any healthy samples with a missing age, or missing Ab features were 603 removed (n=9). When analysing COVID-19 samples with healthy samples, only the features where 604 data was available for all COVID-19 samples were included. COVID-19 samples lacked entire 605 datasets for IgG4, IgA2, FcgRIIaR131, FcgRIIIaF158, and FcgRIIb, thus these detectors were 606 excluded. When COVID-19 samples were analysed based on the time from disease onset, all visit 607 days were used for each patient. In all other analyses when a patient has two visit days only the 608 second visit was used. Right shifting was performed on each feature (detector-antigen pair) 609",
            "latex": null,
            "type": "figure"
        },
        "FIGREF18": {
            "text": "HLA-II alleles influence Ab signatures 772 HLA-DQB1, -DRB1 and -DPB1 alleles in our healthy donor cohort (a,d,g), PLSDA scores (b,e,h) and 773 loadings (c,f,i) plots using the Elastic-Net selected signatures for the two most frequent alleles (HLA-774 DQB1*03:01 and 06:02, 17.41% cross-validation error, 13.56% calibration error; HLA-DRB1*15:01 775 and 07:01, 23.68% cross-validation error, 20.17% calibration error; HLA-DPB1*04:01 and 02:01,",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": ". A separate highly 155 correlated IgM network of multiple CoV NP antigens was also observed. Collectively, these data 156 suggest that children may have elevated SARS-CoV-2 Abs with the capacity to engage a range of Fc 157 effector functions to SARS-CoV-2 S, in addition to elevated IgM responses to CoV antigens in 158 comparison to elderly. The elderly predominantly had hCoV functional Ab responses to S protein, 159 mediated by IgG1 and elevated IgA1 to SARS-CoV-2 RBD, correlative with IgA1 and IgA2 S and",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": ". Strikingly, a 221 supervised PLSDA model of these four features, all associated with COVID-19 patients, could 222 significantly distinguish all COVID-19 patients from healthy individuals on LV1 alone(Figure 3e",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": ". https://doi.org/10.1101//doi.org/10. /2020 humoral immunity and would require a sufficiently large cohort of HLA-typed healthy controls and 294 COVID-19 patients.We also assessed the CoV serological profiles of a small cohort of COVID-19 patients, observing 297 distinct SARS-CoV-2 Fc Ab signatures associated with enhanced engagement of Fc\u03b3RIIIaV158 and C1q, distinguishing healthy controls from COVID-19 patients. Ab Fc binding to Fc\u03b3R can be 299 modulated by multiple structural, genetic, and post-translational modifications, including Fc 300 glycosylation19,35  . Within convalescent plasma samples, we observed upregulation of SARS-CoV-2 antigen-specific IgG, particularly IgG3, which highly correlated with Fc\u03b3R and C1q engagement, 302 suggesting that Fc functional responses may contribute to recovery. Fc effector functions, while 303 beneficial against many pathogens15,16,22,36  , can also enhance infection and pathogenesis in other 304 infectious diseases, including dengue, where disease severity is associated with afucosylated IgG1 305 that enhances Fc\u03b3RIIIa affinity 37 . This is also observed with other respiratory diseases including 306 tuberculosis, where greater overall inflammation, including inflammatory Fc glycosylation is 307 associated with poorer disease outcomes 36,38 . It is important for future larger SARS-CoV-2 serological 308 studies to assess not only quantitative changes in Ab titers, but also qualitative differences between 309 patients with mild and severe disease, whereas in our study the majority of patients had mild-to-310 moderate COVID-19.",
            "latex": null,
            "type": "table"
        },
        "TABREF4": {
            "text": "Chung, A. W. et al. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology. Cell 163, 988-998, doi:10.1016/j.cell.2015.10.027 (2015).system via FcgammaR function in immune therapy: a pathway to next-gen mAbs. Immunol",
            "latex": null,
            "type": "table"
        },
        "TABREF6": {
            "text": ", PLSDA scores (b,e,h) and 440 loadings (c,f,i) plots using the Elastic-Net selected signatures for the two most frequent alleles (HLA-DQB1*03:01 and 06:02, 17.41% cross-validation error, 13.56% calibration error; HLA-DRB1*15:01 442 and 07:01, 23.68% cross-validation error, 20.17% calibration error; HLA-DPB1*04:01 and 02:01, 443 25.78% cross-validation error, 17.66% calibration error). Variance explained on each LV is in 444 parentheses. Analysis was performed on a subset of the healthy individuals (n=111) for whom HLA 445 class II type was available. Donors heterozygotes for the two most frequent HLA alleles were 446 excluded from PLSDA and loading analysis.",
            "latex": null,
            "type": "table"
        },
        "TABREF7": {
            "text": ". https://doi.org/10.1101//doi.org/10. /2020 above. For the detection of Fc\u03b3R, soluble recombinant Fc\u03b3R dimers (higher affinity polymorphisms Fc\u03b3RIIa-H131, lower affinity polymorphisms Fc\u03b3RIIa-R131, Fc\u03b3RIIb, higher affinity polymorphisms Fc\u03b3RIIIa-V158, lower affinity polymorphisms Fc\u03b3RIIIa-F158) were provided by Bruce Wines and 553 Mark Hogarth. For the detection of C1q, C1q protein (MP Biomedicals) was first biotinylated 554 (Thermo Fisher Scientific), washed and resuspended in PBS and tertramerized with SAPE. Dimers or 555 tetrameric C1q-PE were added at 1\u00b5g/ml, 25\u00b5l per well, incubated at RT for two hours on a shaker, 556 then washed. For Dimers, SAPE was added at 1\u00b5g/ml, 25\u00b5l per well, incubated at RT for two hours 557 on a shaker before being washed and read as mentioned above. Assays were repeated in duplicate. A",
            "latex": null,
            "type": "table"
        },
        "TABREF8": {
            "text": "",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "size, or sampled all classes at the size of the smallest class for categorical outcomes, which corrected 625 for any potential effects of class size imbalances during regularization. Elastic-Net regularization was 626 then applied to each of the 2000 resampled subsets to reduce and select features most associated with 627 the outcome variables. The Elastic-Net hyperparameter, alpha, was set to have equal weights between 628 the L1 norm and L2 norm associated with the penalty function for least absolute shrinkage and 629 selection (LASSO) and ridge regression, respectively 42 . By using both penalties, Elastic-Net provides 630 sparsity and promotes group selection. The frequency at which each feature was selected across the 631 2000 iterations was used to determine the signatures by using a sequential step-forward algorithm that 632 iteratively added a single feature into the PLSR (numerical outcome) or PLSDA (categorical 633 outcome) model starting with the feature that had the highest frequency of selection, to the lowest 634 frequency of selection. Model prediction performance was assessed at each step and evaluated by 10-635 fold cross-validation classification error for categorical outcomes and 10-fold goodness of prediction 636 (Q 2 ) for numerical outcomes. The model with the lowest classification error and highest Q 2 within a 637 0.01 difference between the minimum classification error or the maximum Q 2 were selected as the 638 minimum signature. If multiple models fell within this range, the one with the least number of 639 features was selected and if there was a large disparity between calibration and cross-validation error 640 (overfitting), the model with the least disparity and best performance was selected. Matlab, was used in conjunction with Elastic-Net, described above, to identify and visualize 656 signatures that distinguish categorical outcomes (age cohort, COVID-19 infection status). This 657 supervised method assigns a loading to each feature within a given signature and identifies the linear 658 combination of loadings (a latent variable) that best separates the categorical groups. A feature with a 659 high loading magnitude indicates greater importance for separating the groups from one another. Each 660 sample is then scored and plotted using their individual response measurements expressed through the 661 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020. . https://doi.org/10. 1101 /2020 19 latent variables (LVs). The scores and loadings can then be cross referenced to determine which 662 features are loaded in association with which categorical groups (positively loaded features are higher 663 in positively scoring groups etc). All models go through 10-fold cross-validation, where iteratively 664 10% of the data is left out as the test set, and the rest is used to train the model. Model performance is 665 measured through calibration error (average error in the training set) as well as cross-validation error 666 (average error in the test set), with values near zero being best. All models were orthogonalized to 667 enable clear visualization of results. Statistically significant separation of groups on the PLSDA score 668 plots was determined using a two-tailed t-test on LV1 scores in Prism 8. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 95,
                    "end": 99,
                    "text": "1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": "The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 and mild cases were coloured black, while moderate to severe cases were coloured orange. For 828 comparison, two healthy elderly plasma were included (green). DD1, who was SARS CoV-2-exposed 829 but remained SARS CoV-2 PCR-negative, was also included (purple). ",
            "cite_spans": [
                {
                    "start": 59,
                    "end": 71,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 72,
                    "end": 99,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 100,
                    "end": 105,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "(which was not certified by peer review)"
        },
        {
            "text": ". CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)The copyright holder for this preprint this version posted May 18, 2020 . . https://doi.org/10.1101 /2020 ",
            "cite_spans": [
                {
                    "start": 263,
                    "end": 275,
                    "text": "May 18, 2020",
                    "ref_id": null
                },
                {
                    "start": 276,
                    "end": 303,
                    "text": ". . https://doi.org/10.1101",
                    "ref_id": null
                },
                {
                    "start": 304,
                    "end": 309,
                    "text": "/2020",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "842"
        }
    ]
}